NDC 50090-0505-05 - Glipizide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0505
- Requested NDC
- 50090-0505-05
- Package NDCs from labels
- 50090-0505-6, 50090-0505-5, 50090-0505-1, 50090-0505-4, 50090-0505-0, 50090-0505-2, 50090-0505-05
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-10-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glipizide - A-S Medication Solutions | A-S Medication Solutions | 2026-10-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0505-0 | Glipizide | 30 in 1 BOTTLE | TABLET | 30 | 15 | |
| 50090-0505-1 | Glipizide | 60 in 1 BOTTLE | TABLET | 60 | 15 | |
| 50090-0505-2 | Glipizide | 100 in 1 BOTTLE | TABLET | 100 | 15 | |
| 50090-0505-4 | Glipizide | 200 in 1 BOTTLE | TABLET | 200 | 15 | |
| 50090-0505-5 | Glipizide | 90 in 1 BOTTLE | TABLET | 90 | 15 | |
| 50090-0505-6 | Glipizide | 180 in 1 BOTTLE | TABLET | 180 | 15 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0505 | GLIPIZIDE TABLET [A-S MEDICATION SOLUTIONS] | 13 | Current NDC, Legacy NDC, 6 package rows | 20231210_a38cfe61-4aa5-498c-bca5-03a8213303bb.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0505-0 | EA - Each | 50090-0505 | 0d84ed51-94f6-41ed-b3ef-460e30340b28 | 1 | 2018-09-05 |
| 50090-0505-1 | EA - Each | 50090-0505 | e01f53a5-a339-4e63-a89a-30f448455a90 | 1 | 2021-08-05 |
| 50090-0505-2 | EA - Each | 50090-0505 | dff0f5a2-7b44-475d-a057-5c04a247e2d3 | 1 | 2018-09-05 |
| 50090-0505-5 | EA - Each | 50090-0505 | e192b278-506c-49e0-96b9-c41f1039cb5e | 1 | 2018-09-05 |
| 50090-0505-6 | EA - Each | 50090-0505 | 22a5ccb8-5423-4ec8-90ec-ff2e4d480f55 | 1 | 2018-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glipizide and metformin hcl | GLIPIZIDE AND METFORMIN HCL | Chartwell RX, LLC | ac018f64-fd9d-4b3c-b0ac-ca305b8df635 | 2026-11-05 | Boxed warning, Adverse reactions | X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 726fd41e-7831-4f94-8b28-d139105aad68 | 2026-11-04 | Warnings, Adverse reactions | 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | Bryant Ranch Prepack | a59e2aaf-692c-4696-817b-3fed7a9dc52c | 2026-11-04 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | a38cfe61-4aa5-498c-bca5-03a8213303bb | 2026-10-14 | Warnings, Adverse reactions | ANDA075795 50090-0505-6 50090-0505-4 50090-0505-2 50090-0505-1 50090-0505-5 50090-0505-0 50090-0505 50090050505 310488 8e48ae75-25df-4dda-8a0b-10beb4d8d39b a38cfe61-4aa5-498c-bca5-03a8213303bb X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 16fb8bc7-1db1-477e-a201-b3b678b8a84c | 2026-10-13 | Warnings, Adverse reactions | ANDA075795 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | AiPing Pharmaceutical, Inc. | ccfa5a38-3f90-48f4-b226-51e91497c06f | 2026-10-09 | Warnings, Adverse reactions | 310488 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | AiPing Pharmaceutical, Inc. | 2110a7ca-3c1f-4db4-9211-65546b74533c | 2026-10-09 | Warnings, Adverse reactions | 310488 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 41d4e09b-b90c-4243-acd8-f2e06ebf4089 | 2026-10-09 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | 861609da-6f69-43cf-a6a3-9f45a1d9eb23 | 2026-10-02 | Warnings, Adverse reactions | 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | c38c3c72-0ef2-4c06-8c67-a3f428ad172b | 2026-10-02 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | NuCare Pharmaceuticals, Inc. | 5ce323e4-ea8c-22b5-e063-6294a90a15bf | 2026-10-02 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 04e18105-0bd2-4353-b7d2-a73749de32b8 | 2026-09-29 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | d9b6464f-6fe6-446e-8150-d0c15c46fee8 | 2026-09-28 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | 1b2e5656-9da9-4fab-bf01-ed75896b836a | 2026-09-23 | Warnings, Adverse reactions | ANDA075795 310488 X7WDT95N5C |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | 3f2599c6-9e33-487e-9379-6477bb121461 | 2026-09-22 | Warnings, Adverse reactions | X7WDT95N5C |
| Glipizide | GLIPIZIDE | REMEDYREPACK INC. | 212897cb-7de7-4711-aaf4-44234f950e9f | 2026-09-22 | Warnings, Adverse reactions | ANDA075795 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | REMEDYREPACK INC. | 376ce3cf-4e1b-4b5f-b3e7-cc9fc4a5aeb4 | 2026-09-22 | Warnings, Adverse reactions | ANDA075795 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | Oxford Pharmaceuticals, LLC | 87cd4930-ba68-4acf-bf74-619c477b557d | 2026-09-17 | Warnings, Adverse reactions | 310488 310490 X7WDT95N5C |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| Glipizide | GLIPIZIDE | NuCare Pharmaceuticals,Inc. | 6282c653-9e9c-6810-e053-2991aa0a4a8e | 2026-09-14 | Warnings, Adverse reactions | ANDA075795 310490 X7WDT95N5C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.